CRISPR Therapeutics AG
MATERIALS AND METHODS FOR TREATMENT OF PAIN RELATED DISORDERS

Abstract:

The present application provides materials and methods for treating a patient with one or more conditions associated with SCN10A whether ex vivo or in vivo. In addition, the present application provides materials and methods for editing and/or modulating the expression of SCN10A gene in a cell by genome editing.